KULIAKANDA CHENGAPPA: Open Payments
NPI 1376558825 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,202 in 112 payments from 14 companies in 2025. Trend: 2023 $1,741 · 2024 $1,831 · 2025 $2,202
Food & beverage: $2,202
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $540 |
| E.R. Squibb & Sons, L.L.C. | 14 | $319 |
| Vanda Pharmaceuticals Inc. | 13 | $256 |
| Alkermes, Inc. | 9 | $232 |
| Otsuka America Pharmaceutical, Inc. | 13 | $226 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $141 |
| Axsome Therapeutics, Inc. | 2 | $140 |
| Neurocrine BioSciences, Inc. | 5 | $109 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| Lundbeck LLC | 3 | $55 |
Products named: VRAYLAR, COBENFY, HETLIOZ, REXULTI, CAPLYTA, Auvelity, LYBALVI, INGREZZA.
Industry payments across NC — which companies pay providers there.
